The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Roche
Correlation of pre- and post-induction plasma mutant allele fraction with progression-free survival (PFS) in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC).
 
John J. Lee
Employment - Roche
Travel, Accommodations, Expenses - Roche
 
John F. Palma
Employment - Roche
Stock and Other Ownership Interests - Clovis Oncology; Exact Sciences; Johnson & Johnson; Roche
Patents, Royalties, Other Intellectual Property - Affymetrix; Johnson & Johnson; Metabolex
 
Lijing Yao
Employment - Roche
 
Alexander F. Lovejoy
Employment - Roche
 
Stephanie Yaung
Employment - Roche
 
David Zhang
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Nasiema Wingate-Pearse
Employment - Roche
Stock and Other Ownership Interests - Galena Biopharma
 
May Yau
Employment - Roche
 
Carolyn Williams
Employment - Roche
 
Monica Pimentel
Employment - Roche; Roche (I)
 
Abraham Munoz
Employment - Roche
 
Katrina Mayol
Employment - Roche
 
Christoph Mancao
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent
 
Alan Nicholas
Employment - Genentech; Mallinckrodt
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Nicolas Sommer
No Relationships to Disclose
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
Johanna C. Bendell
Research Funding - Abbott/AbbVie (Inst); Agios (Inst); Apexigen (Inst); ARMO BioSciences (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Onyx (Inst); Sanofi (Inst); Stem CentRx (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TG Therapeutics (Inst)
 
Ulrich Peter Rohr
Employment - Roche
Leadership - Roche
Stock and Other Ownership Interests - Roche